Did Sperm and Egg Donors Unwittingly Contribute to NIH-Approved Stem Cells?
By Jocelyn Kaiser,
ScienceInsider
| 02. 07. 2013
A review of the 200 or so human embryonic stem cell (hESC) lines
approved by the National Institutes of Health (NIH) for federal funding has found a possible ethical problem: Some of the cells may have come from sperm or egg donors who didn't consent to having their cells used in research. University oversight committees should be aware that these cell lines may not meet widely accepted standards, the authors say.
In July 2009, following an order from President Barack Obama, NIH
issued guidelines laying out ethical standards that all hESC lines studied with NIH funding must meet. The cell lines must have been derived from surplus embryos donated by couples receiving fertility treatments, for example. But the guidelines
don't discuss the possibility that some embryos made have been created using donor eggs or sperm, even though 2005 National Academy of Sciences (NAS) guidelines call for consent from gamete donors. Research administrators at the Rockefeller University in New York City became concerned about this gap last year after a survey suggested that U.S. in vitro fertilization (IVF) clinics usually don't...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...